癲癇是目前有關(guān)癲癇各方面臨床和研究成果的領(lǐng)先、最權(quán)威的資料來(lái)源。作為《國(guó)際抗癲癇聯(lián)盟雜志》，每月的訂閱者將回顧以下領(lǐng)域的科學(xué)證據(jù)和臨床方法:臨床神經(jīng)學(xué)、神經(jīng)生理學(xué)、分子生物學(xué)、神經(jīng)影像學(xué)、神經(jīng)化學(xué)、神經(jīng)外科、藥理學(xué)、神經(jīng)流行病學(xué)和治療試驗(yàn)。在每一期中，訂閱者將發(fā)現(xiàn)同行評(píng)審的原始文章、癲癇研究進(jìn)展、簡(jiǎn)要通信、編輯評(píng)論、特別補(bǔ)刊、會(huì)議報(bào)告、書(shū)評(píng)和公告。

Epilepsia is the leading, most authoritative source for current clinical and research results on all aspects of epilepsy. As the journal of the International League Against Epilepsy, subscribers every month will review scientific evidence and clinical methodology in: clinical neurology, neurophysiology, molecular biology, neuroimaging, neurochemistry, neurosurgery, pharmacology, neuroepidemiology, and therapeutic trials. In each issue subscribers will find original peer reviewed articles, progress in epilepsy research, brief communications, editorial commentaries, special supplements, meeting reports, book reviews, and announcements.